Da Zen Theranostics

United States
Bethlehem, West Virginia, United States, 95123

Company profile

Da Zen Theranostics company profile

Da Zen Theranostics develop a product that can target cancer cells, function as a contrast agent to improve the visibility of cancer cells. It functions as a contrast agent to improve the visibility of cancer cells during diagnostic imaging and deliver a therapeutic drug to destroy cancerous cells. The product will be based on a chemical compound that was created by Dr. Maged Henary, associate professor of chemistry at Georgia State. Henary’s chemical compound, a heptamethine cyanine also known to the scientific community as MHI-148, is already being used internationally in cancer imaging research. The company was founded in 2017 and is based in San Jose, California.

Business identity

Phone number
408-489-9383
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2017-01-01, Year

Headquarters

Postal code
95123
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$2.3M
Last funding
Seed / $700,000 / 2019-07-17
Last equity funding
Seed / $700,000
Founders
1
Articles
10

Founders and investors

Founders

Leland W.K. Chung